These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 12242463)

  • 1. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes.
    Antonelli A; Tuomi T; Nannipieri M; Fallahi P; Nesti C; Okamoto H; Groop L; Ferrannini E
    Diabetologia; 2002 Sep; 45(9):1298-306. PubMed ID: 12242463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.
    Mallone R; Ortolan E; Pinach S; Volante M; Zanone MM; Bruno G; Baj G; Lohmann T; Cavallo-Perin P; Malavasi F
    Diabetologia; 2002 Dec; 45(12):1667-77. PubMed ID: 12488956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
    Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
    Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3.
    Petrone A; Suraci C; Capizzi M; Giaccari A; Bosi E; Tiberti C; Cossu E; Pozzilli P; Falorni A; Buzzetti R;
    Diabetes Care; 2008 Mar; 31(3):534-8. PubMed ID: 18056891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD38 autoimmunity: recent advances and relevance to human diabetes.
    Antonelli A; Ferrannini E
    J Endocrinol Invest; 2004; 27(7):695-707. PubMed ID: 15505998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
    Römkens TE; Kusters GC; Netea MG; Netten PM
    Neth J Med; 2006 Apr; 64(4):114-8. PubMed ID: 16609158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamic acid decarboxylase autoantibody prevalence and association with HLA genotype in patients with younger-onset type 1 diabetes and proliferative diabetic retinopathy.
    Mimura T; Funatsu H; Uchigata Y; Kitano S; Shimizu E; Amano S; Yamagami S; Noma H; Araie M; Hori S
    Ophthalmology; 2005 Nov; 112(11):1904-9. PubMed ID: 16157380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes.
    Castleden HA; Shields B; Bingley PJ; Williams AJ; Sampson M; Walker M; Gibson JM; McCarthy MI; Hitman GA; Levy JC; Hattersley AT; Vaidya B; Pearson ER
    Diabet Med; 2006 Aug; 23(8):834-8. PubMed ID: 16911619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD38 autoantibodies in type? diabetes.
    Mallone R; Perin PC
    Diabetes Metab Res Rev; 2006; 22(4):284-94. PubMed ID: 16544364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.
    Buzzetti R; Di Pietro S; Giaccari A; Petrone A; Locatelli M; Suraci C; Capizzi M; Arpi ML; Bazzigaluppi E; Dotta F; Bosi E;
    Diabetes Care; 2007 Apr; 30(4):932-8. PubMed ID: 17392553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study.
    Kukko M; Kimpimäki T; Kupila A; Korhonen S; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M
    Diabetologia; 2003 Jan; 46(1):65-70. PubMed ID: 12637984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence of diabetes-specific CD38 (ADP ribosil cyclase/cyclic ADP-ribose hydrolase) autoantibodies by liquid-phase immunoprecipitation.
    Sordi V; Lampasona V; Cainarca S; Bonifacio E
    Diabet Med; 2005 Dec; 22(12):1770-3. PubMed ID: 16401328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune diabetes in adults: lessons from the UKPDS.
    Desai M; Clark A
    Diabet Med; 2008 Aug; 25 Suppl 2():30-4. PubMed ID: 18717976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
    Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets.
    Pupilli C; Giannini S; Marchetti P; Lupi R; Antonelli A; Malavasi F; Takasawa S; Okamoto H; Ferrannini E
    Diabetes; 1999 Dec; 48(12):2309-15. PubMed ID: 10580418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
    Reinsch B; Zimmy S; Schatz H; Pfohl M
    Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
    Goel A; Chiu H; Felton J; Palmer JP; Brooks-Worrell B
    Diabetes; 2007 Aug; 56(8):2110-5. PubMed ID: 17473222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
    Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
    Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
    Wang JP; Zhang C; Lin J; Yuan Y; Zhou HF; Huang G; Zhou M; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2380-4. PubMed ID: 18036312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
    Tiberti C; Giordano C; Locatelli M; Bosi E; Bottazzo GF; Buzzetti R; Cucinotta D; Galluzzo A; Falorni A; Dotta F
    Diabetes; 2008 May; 57(5):1276-83. PubMed ID: 18332100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.